TTRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 07, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Turn Therapeutics Inc (TTRX)

Based on 8 analysts giving stock ratings to Turn Therapeutics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
62
Hold
13
Sell
0
Strong Sell
0
Turn Therapeutics Inc

Turn Therapeutics Inc. Stock Analysis TTRX

United States Health Care Micro Cap Report:
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
Read More

Turn Therapeutics Inc (TTRX) Chart

Key Statistics of Turn Therapeutics Inc (TTRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.78$4.07

Today's Open

$3.90

Volume

29.43K

P/E Ratio (TTM)

-

52 Week Range

$2.57$26.50

Market Cap

110.22M

Avg. Volume

22.27K

Dividend Yield

-

Financial Metrics & Statements of Turn Therapeutics Inc (TTRX)

FAQ's for Turn Therapeutics Inc (TTRX)

  • According to Musaffa’s Shariah screening methodology, Turn Therapeutics Inc (TTRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.